1-(3-OXETANYL)-1H-PYRAZOL-4-AMINE, 95.0%, 250mg

2-AMINO-2-(OXETAN-3-YL)ACETIC ACID, 95.0%, 250mg

Diisopropilamina, mínimo 99,5 %, para síntesis, 500 ml, envase de vidrio

8-Bromo-[1,2,4]triazolo[4,3-c]pyrimidine, 95.0%, 250mg

5-bromoquinolin-6-amine, 95.0%, 250mg

2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide, 97.00%, 100mg

METHYL 2-AMINO-3,5-DIFLUOROBENZOATE, 95.0%, 1g

(5-Bromofuran-2-yl)methanamine hydrochloride, 98%, 100mg

5-Methyl-2-(3-trifluoromethyl-phenylamino)-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

(Methoxymethyl)triphenylphosphonium chloride, 98.0%, 1kg

7-bromo-2,4,6-trichloro-8-fluoroquinazoline, 95.0%, 1g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste externo, no certificados, 0,001 g, 420 g, BCE423-1S (W)

6,7-Dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol, 97%, 250mg